bioAffinity Technologies (BIAF) Asset Utilization Ratio (2023 - 2026)

bioAffinity Technologies (BIAF) has 4 years of Asset Utilization Ratio data on file, last reported at 0.6 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.6, down 59.01% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.6 (down 59.01% YoY), and the FY2025 annual result was 0.71, down 44.5% from the prior year.
• Asset Utilization Ratio advanced to 0.6 in Q1 2026 per BIAF's latest filing, from 0.55 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.49 in Q2 2025 and troughed at 0.0 in Q1 2023.
• A 4-year average of 0.75 and a median of 0.61 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio soared 119993.65% in 2024, then tumbled 61.79% in 2025.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.28 in 2023, then jumped by 420.91% to 1.43 in 2024, then plunged by 61.79% to 0.55 in 2025, then grew by 9.35% to 0.6 in 2026.
• Business Quant data shows BIAF's Asset Utilization Ratio at 0.6 in Q1 2026, 0.55 in Q4 2025, and 0.83 in Q3 2025.